Literature DB >> 15789427

Whole-mount analysis reveals normal numbers of dopaminergic neurons following misexpression of alpha-Synuclein in Drosophila.

Yakov Pesah1, Heather Burgess, Brooke Middlebrooks, Kari Ronningen, Jude Prosser, Vijaya Tirunagaru, John Zysk, Graeme Mardon.   

Abstract

Previously published reports have suggested that misexpression of alpha-Synuclein in the Drosophila central nervous system causes neurodegeneration and progressive age-dependent locomotor dysfunction similar to pathologic and clinical manifestations of Parkinson's disease. The number of dopaminergic (DA) neurons in these studies was assessed using immunohistochemistry with an anti-tyrosine hydroxylase antibody on sequential paraffin sections of fly brains. In contrast, we do not observe any DA cell loss in alpha-Synuclein expressing fly brains when using whole-mount immunohistochemistry as an assay. Our results suggest that the DA cell loss observed with misexpression of alpha-Synuclein is not fully penetrant under a variety of experimental conditions and that this may complicate interpretation of such experiments. Copyright (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15789427     DOI: 10.1002/gene.20106

Source DB:  PubMed          Journal:  Genesis        ISSN: 1526-954X            Impact factor:   2.487


  26 in total

1.  Developmental analysis of the dopamine-containing neurons of the Drosophila brain.

Authors:  Volker Hartenstein; Louie Cruz; Jennifer K Lovick; Ming Guo
Journal:  J Comp Neurol       Date:  2016-07-11       Impact factor: 3.215

Review 2.  Genetic animal models of Parkinson's disease.

Authors:  Ted M Dawson; Han Seok Ko; Valina L Dawson
Journal:  Neuron       Date:  2010-06-10       Impact factor: 17.173

Review 3.  Human disease models in Drosophila melanogaster and the role of the fly in therapeutic drug discovery.

Authors:  Udai Bhan Pandey; Charles D Nichols
Journal:  Pharmacol Rev       Date:  2011-03-17       Impact factor: 25.468

Review 4.  Neurodegenerative models in Drosophila: polyglutamine disorders, Parkinson disease, and amyotrophic lateral sclerosis.

Authors:  Surendra S Ambegaokar; Bidisha Roy; George R Jackson
Journal:  Neurobiol Dis       Date:  2010-05-31       Impact factor: 5.996

5.  Effects of small-molecule amyloid modulators on a Drosophila model of Parkinson's disease.

Authors:  Małgorzata Pokrzywa; Katarzyna Pawełek; Weronika Elżbieta Kucia; Szymon Sarbak; Erik Chorell; Fredrik Almqvist; Pernilla Wittung-Stafshede
Journal:  PLoS One       Date:  2017-09-01       Impact factor: 3.240

Review 6.  Molecular mechanisms of alpha-synuclein neurodegeneration.

Authors:  Elisa A Waxman; Benoit I Giasson
Journal:  Biochim Biophys Acta       Date:  2008-10-09

7.  Selective degeneration of dopaminergic neurons by MPP(+) and its rescue by D2 autoreceptors in Drosophila primary culture.

Authors:  Lyle Wiemerslage; Bradley J Schultz; Archan Ganguly; Daewoo Lee
Journal:  J Neurochem       Date:  2013-03-24       Impact factor: 5.372

8.  The therapeutic potential of LRRK2 and alpha-synuclein in Parkinson's disease.

Authors:  Saurabh Sen; Andrew B West
Journal:  Antioxid Redox Signal       Date:  2009-09       Impact factor: 8.401

9.  An optimized method for histological detection of dopaminergic neurons in Drosophila melanogaster.

Authors:  Daria Drobysheva; Kristen Ameel; Brandon Welch; Esther Ellison; Khan Chaichana; Bryan Hoang; Shilpy Sharma; Wendi Neckameyer; Irina Srinakevitch; Kelley J Murphy; Aloisia Schmid
Journal:  J Histochem Cytochem       Date:  2008-06-23       Impact factor: 2.479

Review 10.  Modelling Parkinson's disease in Drosophila.

Authors:  José A Botella; Florian Bayersdorfer; Florian Gmeiner; Stephan Schneuwly
Journal:  Neuromolecular Med       Date:  2009-10-24       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.